Study Design and Population

JG Jessica A Grembi
AL Audrie Lin
MK Md Abdul Karim
MI Md Ohedul Islam
RM Rana Miah
BA Benjamin F Arnold
EM Elizabeth T Rogawski McQuade
SA Shahjahan Ali
MR Md Ziaur Rahman
ZH Zahir Hussain
AS Abul K Shoab
SF Syeda L Famida
MH Md Saheen Hossen
PM Palash Mutsuddi
MR Mahbubur Rahman
LU Leanne Unicomb
RH Rashidul Haque
MT Mami Taniuchi
JL Jie Liu
JP James A Platts-Mills
SH Susan P Holmes
CS Christine P Stewart
JB Jade Benjamin-Chung
JJ John M Colford, Jr
EH Eric R Houpt
SL Stephen P Luby
ask Ask a question
Favorite

The WASH Benefits Bangladesh study measured the impact of WSH and nutrition interventions on child growth, development, and parasitic infection (ClinicalTrials.gov, NCC01590095) [22, 24, 25, 29, 30]. Intervention arms included drinking water treatment, sanitation, handwashing, combined WSH, nutrition, and combined N+WSH. This analysis includes children enrolled in the environmental enteric dysfunction substudy, which was a subsample of clusters from the WSH, nutrition, N+WSH, and control arms (in a 1:1:1:1 ratio) [31, 32]. Interventions were delivered while mothers were pregnant, so children were exposed to interventions from birth; a detailed description of interventions has been provided previously [22]. In brief, the WSH intervention consisted of chlorine tablets and a safe drinking water storage vessel; a dual-pit latrine with a water seal, child potties, and hoes for feces disposal; and handwashing stations (including detergent soap with dispensers) near the latrine and kitchen. The nutrition intervention consisted of age-appropriate infant feeding recommendations plus lipid-based nutrient supplements twice daily from age 6 months to 24 months. The N+WSH intervention combined the WSH and nutrition packages. Behavior change messaging was delivered 6 times per month to intervention households, which resulted in high adherence [22]. Rotavirus vaccination had not been implemented in Bangladesh at the time of the study.

Although enteropathogen prevalence tends to increase with age over the first 2 years of life, the importance of early pathogen carriage on later health outcomes (eg, stunting and cognitive deficits [5, 33]) motivated us to evaluate children at a younger age (14 ± 2 months) than the parasite studies (30 ± 2 months) [31, 32]. Written informed consent was obtained from parents of all children. The trial was approved by human subjects committees at the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b; PR-11063), the University of California, Berkeley (2011-09-3652), and Stanford University (25863).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A